The MEDIMMUNE brand, founded in 2004 (United States), from 585 sister brands and 17478 competing brands. The MEDIMMUNE brand is owned by ASTRAZENECA, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB0009895292. MEDIMMUNE is part of the Drug Manufacturers activity sector.